Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lechat

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|October 16, 2007
Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseasesGaëlle Leroux, Nathalie Costedoat-Chalumeau, Jean-Sébastien Hulot, et al.
British Journal of Clinical Pharmacology|September 29, 2005
Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysisPaola Sanchez-Pena, Jean-Sébastien Hulot, Saïk Urien, et al.
Blood|June 15, 2006
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsJean-Sébastien Hulot, Alessandra Bura, Eric Villard, et al.
The Journal of Infectious Diseases|November 4, 2006
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathyHassane Izzedine, Jean-Sebastien Hulot, Eric Villard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2008
RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the ratFleur C Aubart, Yassine Sassi, Alain Coulombe, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
Population pharmacokinetic study of methotrexate in patients with lymphoid malignancyDemiana William Faltaos, Jean Sebastian Hulot, Saïk Urien, et al.
British Journal of Clinical Pharmacology|March 13, 2003
Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methodsJean-Sébastien Hulot, Michel Cucherat, Andrew Charlesworth, et al.
European Heart Journal|July 15, 2005
Prognostic benefit of beta-blockers in patients not receiving ACE-InhibitorsHenry Krum, Steven Joseph Haas, Eric Eichhorn, et al.
European Journal of Heart Failure|June 9, 2004
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-IIIRonnie Willenheimer, Erland Erdmann, Ferenc Follath, et al.
European Heart Journal|August 11, 2004
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of CardiologyJosé López-Sendón, Karl Swedberg, John McMurray, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|October 16, 2007
Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseasesGaëlle Leroux, Nathalie Costedoat-Chalumeau, Jean-Sébastien Hulot, et al.
British Journal of Clinical Pharmacology|September 29, 2005
Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysisPaola Sanchez-Pena, Jean-Sébastien Hulot, Saïk Urien, et al.
Blood|June 15, 2006
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsJean-Sébastien Hulot, Alessandra Bura, Eric Villard, et al.
The Journal of Infectious Diseases|November 4, 2006
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathyHassane Izzedine, Jean-Sebastien Hulot, Eric Villard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2008
RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the ratFleur C Aubart, Yassine Sassi, Alain Coulombe, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
Population pharmacokinetic study of methotrexate in patients with lymphoid malignancyDemiana William Faltaos, Jean Sebastian Hulot, Saïk Urien, et al.
British Journal of Clinical Pharmacology|March 13, 2003
Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methodsJean-Sébastien Hulot, Michel Cucherat, Andrew Charlesworth, et al.
European Heart Journal|July 15, 2005
Prognostic benefit of beta-blockers in patients not receiving ACE-InhibitorsHenry Krum, Steven Joseph Haas, Eric Eichhorn, et al.
European Journal of Heart Failure|June 9, 2004
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-IIIRonnie Willenheimer, Erland Erdmann, Ferenc Follath, et al.
European Heart Journal|August 11, 2004
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of CardiologyJosé López-Sendón, Karl Swedberg, John McMurray, et al.
Pageof 11